Josip Fajdić

Sexual Dysfunction in Breast Cancer Survivors

Aim: The aim of this study was to determine differences in body image and sexuality of breast cancer survivors, depending on treatment: radical mastectomy or breast-conserving surgery. Patients and Methods: A total of 206 patients treated for breast cancer between January 2001 and January 2004 were asked to fill in the questionnaire 1-5 years after treatment. Patients were divided into 2 groups. The first group consisted of 108 patients with advanced stages of breast cancer and who were treated with modified mastectomy with adjuvant chemo- or radiation therapy. The second group consisted of 98 patients with early stages of breast cancer who were treated with breast conserving surgery, lumpectomy and radiotherapy. Results: A significant number of patients in both groups was satisfied with their sexual life before treatment, 70.37 and 73.47% respectively, which is grossly reduced after treatment of breast cancer (56.48 and 50.00%, respectively, p > 0.05). Most of patients found their partner’s attitude towards them to be the same (31.48 and 45.92%), or even better (39.82 and 25.51%) after treatment, and they described them as very supportive and tender. In group 1, 58.33% of patients felt differences in their body image, in contrast to 44.90% in group 2. Similar proportions were observed in both groups for patients who felt mutilated (18.52 vs. 8.16%, p < 0.01). Conclusion: These findings confirm and extend previous reports of impaired sexual functioning among breast cancer survivors.

Phyllodes tumors of the breast diagnostic and therapeutic dilemmas.

Background: This article compares experiences in the diagnosis and treatment of phyllodes tumors from 2 regional institutions with the relevant literature. Patients and Methods: From 1991 to 2005, 2,848 breast cancer patients were treated in our institutions, 36 (1.44%) for phyllodes tumors. The average tumor size was 5.1 cm (range 1.4-19.6). Triple assessment was the standard diagnostic algorithm. Wide excision with tumor-free margins was carried out in 29 (80.5%) cases and mastectomy in 7 (19.4%) cases. Axillary lymphadenectomy was performed in patients with positive lymph nodes. Results: Histology showed the phyllodes tumors to be benign in 27 (75.0%), malignant in 6 (16.6%), and borderline in 3 (8.3%) cases. Follow-up was from 5 months to 16 years. In this period, recurrences of 3 (8.3%) malignant and 2 (5.6%) benign phyllodes tumors were diagnosed and treated. 10 (27.7%) patients treated with wide local excision showed deformities in the form of scarring. The steroid receptor status was of no prognostic value in our patients, and chemotherapy was used in only 1 (2.7%) patient. 5-year survival was 86.2%. Conclusion: Our study shows that tumor size, margin infiltration, mitotic activity and degree of cellular atypia are important prognostic factors. Problems in diagnosing this condition arise from its similarity to fibroadenoma. Although wide local excision is usually the treatment of choice, tumor recurrence is common. Axillary lymphadenectomy in malignant phyllodes tumors is, in our opinion, still controversial.

Fournier Gangrene: Our Approach and Patients

Aim: This retrospective analysis presents our experience in treating Fournier gangrene (FG) and aims to bring in focus diagnostic and therapeutic problems as well as early and aggressive treatment. Patients and Methods: A total of 16 male patients were included in the study. The gastrointestinal form was seen in 5 and the urogenital form in 11 patients. The subjects ranged in age from 39 to 74 years (average 61) for the urogenital, and from 48 to 72 (average 58) for the gastrointestinal form. Other conditions were seen in 9 patients (diabetes mellitus was most common). Most patients were infected with several bacteria. We performed colostomy in 1 patient, orchidectomy in 2 patients, cystostomy in 2 patients and penis amputation in 1 patient. Ultrasound-guided biopsy or aspiration, and CT was also used. Aggressive surgical necrectomy and aggressive antimicrobial therapy was used. Results: Treatment was successful in 14 of 16 patients (87.5%). The length of hospitalization was 19–58 days (average 48) for the urogenital form and 24–56 days (average 41) for the gastrointestinal form. Mortality was 12.5%. A lethal outcome was recorded in two patients infected with methicillin-resistant Staphylococcus aureus. The average time between onset and hospitalization was 3–11 days (5 on average) for urogenital FG and 4–10 days (average 6) for gastrointestinal FG. Treatment was significantly longer in patients with a comorbidity, such as diabetes or liver cirrhosis due to alcohol abuse. Conclusion: Early diagnosis as well as intensive and aggressive treatment are key to successful treatment of FG. Comorbidity increases length of therapy and lowers the chance for recovery. Disease can be seen again several years after the initial outburst.

Criteria and Procedures for Breast Conserving Surgery

Aim Emphasizing circumstances that determine increasingly popular surgical approach of breast conserving surgery (BCS), used in lower grade breast tumors, while maintaining survival that is found when more radical procedures are used. Patients and methods Several leading oncological protocols in the world are compared, using PubMed database, and our own experience. Data gathered are compared to conclusions of Consensus Conference on Breast Conservation (Milan, 2005). Furthermore, surgical contraindications found in our everyday work are considered, having in mind satisfactory cosmetic outcome, as well as keeping the 1 cm border of “clear” edges. Such more practical problems of edge detection can compromise BCS results. Results After observing several relevant protocols, we found very high frequency of mastectomy vs. BCS, despite the fact that stage of disease was low. We also found only 20% of absolute contraindications for BCS. Most frequent contraindication for BCS was multicentricity of the tumor (with micro calcifications), especially in ductal in situ carcinoma. Conclusion BCS followed by radiation therapy with tumor-free edges is standard procedure in treatment of T1 and small T2 breast cancers. This approach implies higher risk of local recurrence (LR), although local recurrence is low (1% per year), with rates of survival similar to radical procedures.